The Carlyle Group Inc. (CG) Balance Sheet
As of 2026-06-30 (10-Q), The Carlyle Group Inc. (CG) reported total assets of $28.2B, total liabilities of $21.0B and shareholders' equity of $7.2B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $1.3B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CGThe Carlyle Group Inc.Follow CG — free
—
Price chart with a free account
- Market cap
- 13.8B
- P/E TTM
- 40.2
- Dividend yield
- 3.6%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2010 Dec 10 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.62 | 0.57 | 0.97 | 1.24 | 0.99 | 0.67 | 1.00 | 0.63 | 0.79 | 0.99 | 2.47 | 1.36 | 1.44 | 1.27 | 1.97 | 1.26 | |
| Total assets | 17.06 | 31.57 | 35.62 | 35.99 | 32.18 | 9.97 | 12.28 | 12.91 | 13.81 | 15.64 | 21.25 | 21.40 | 21.18 | 23.10 | 29.12 | 28.20 | |
| Long-term debt | — | — | 0.31 | 0.24 | 1.14 | 1.27 | 1.57 | 1.55 | 1.98 | 1.97 | 2.07 | 2.27 | — | — | — | — | |
| Total liabilities | — | 17.98 | 20.89 | 23.14 | 23.26 | 8.52 | 9.33 | 10.08 | 10.84 | 12.71 | 15.54 | 14.58 | 15.39 | 16.76 | 22.06 | 20.98 | |
| Shareholders' equity | — | — | — | — | — | — | — | 2.84 | 2.97 | 2.93 | 5.71 | 6.82 | 5.78 | 6.35 | 7.06 | 7.21 |
USD billions · SEC XBRL
The Carlyle Group Inc. — questions
- How much cash does The Carlyle Group Inc. have?
- $1.3B in cash and cash equivalents as of 2026-06-30.
- What are The Carlyle Group Inc.'s total assets?
- $28.2B as of 2026-06-30.
- What is The Carlyle Group Inc.'s shareholders' equity?
- $7.2B as of 2026-06-30.
Every figure on this page comes from The Carlyle Group Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.